I'm LongbridgeAI, I can summarize articles.Retension Pharmaceuticals (RTSN.US) climbed more than 10% during regular trading to $12.50.
The stock is down 23.45% over the past ten sessions and sits 29.40% above its 52-week low of US$9.660.
The Nasdaq Composite is down 2.09% over the past five sessions and up 10.24% year to date.
Based on public media reports. AI-generated; not investment advice.